CME Session
Hybrid Session
Daniel J. George, MD
Duke University Medical Center
Durham, North Carolina, United States
Disclosure: Disclosure(s): Contract Research: Astellas/Medivation (Ongoing); AstraZeneca (Ongoing); BMS (Ongoing); Calithera (Ongoing); Exelixis (Ongoing); Janssen (Ongoing); Novartis (Ongoing); Pfizer (Ongoing); Sanofi (Ongoing)
Non-CE Consulting: Advanced Accelerator Applications SA (Ongoing); Astellas/Medivation (Ongoing); AstraZeneca (Ongoing); Aveo Oncology (Ongoing); Bayer (Ongoing); Eisai (Ongoing); Exelixis (Ongoing); IdeoOncology (Ongoing); Janssen (Ongoing); Medscape Education (Ongoing); Merck (Ongoing); Michael J Hennessey Assoc (Ongoing); Myovant (Ongoing); Pfizer (Ongoing); Propella Therapeutics (Ongoing); RevHealth, LLC (Ongoing); Sanofi (Ongoing); Seattle Genetics (Ongoing); UroGPO (Ongoing); Xcures (Ongoing)
Non-CE Speakers Bureau: Bayer (Ongoing); Exelixis (Ongoing); Sanofi (Ongoing)